| Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene–drug pairs across ambulatory care settings EJ Cicali, KW Weitzel, AR Elsey, FA Orlando, M Vinson, S Mosley, ... Genetics in Medicine 21 (10), 2264-2274, 2019 | 60 | 2019 |
| How to integrate CYP2D6 phenoconversion into clinical pharmacogenetics: a tutorial EJ Cicali, AL Elchynski, KJ Cook, JT Houder, CD Thomas, DM Smith, ... Clinical Pharmacology & Therapeutics 110 (3), 677-687, 2021 | 46 | 2021 |
| Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE) KT Bain, EJ Schwartz, OV Knowlton, CH Knowlton, J Turgeon Journal of the American Pharmacists Association 58 (3), 281-289. e1, 2018 | 45 | 2018 |
| Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing JD Duarte, R Dalton, AL Elchynski, DM Smith, EJ Cicali, JC Lee, ... Genetics in Medicine 23 (12), 2335-2341, 2021 | 35 | 2021 |
| The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine EJ Schwartz, AM Issa Personalized Medicine 14 (1), 27-35, 2017 | 28 | 2017 |
| How to transition from single‐gene pharmacogenetic testing to preemptive panel‐based testing: a tutorial RJ Marrero, EJ Cicali, MJ Arwood, E Eddy, D DeRemer, BH Ramnaraign, ... Clinical Pharmacology & Therapeutics 108 (3), 557-565, 2020 | 27 | 2020 |
| Implementation of a standardized medication therapy management plus approach within primary care EJ Schwartz, J Turgeon, J Patel, P Patel, H Shah, AM Issa, OV Knowlton, ... The Journal of the American Board of Family Medicine 30 (6), 701-714, 2017 | 27 | 2017 |
| Novel implementation of genotype‐guided proton pump inhibitor medication therapy in children: a pilot, randomized, multisite pragmatic trial EJ Cicali, K Blake, Y Gong, EB Mougey, H Al‐Atrash, N Chambers, ... Clinical and Translational Science 12 (2), 172-179, 2019 | 25 | 2019 |
| Acceptability, feasibility, and utility of integrating pharmacogenetic testing into a child psychiatry clinic K Claudio‐Campos, A Padrón, G Jerkins, J Nainaparampil, R Nelson, ... Clinical and Translational Science 14 (2), 589-598, 2021 | 20 | 2021 |
| A scoping review of the evidence behind cytochrome P450 2D6 isoenzyme inhibitor classifications EJ Cicali, DM Smith, BQ Duong, LG Kovar, LH Cavallari, JA Johnson Clinical Pharmacology & Therapeutics 108 (1), 116-125, 2020 | 19 | 2020 |
| Precision medication: an illustrative case series guiding the clinical application of multi‐drug interactions and pharmacogenomics KT Bain, D McGain, EJ Cicali, CH Knowlton, V Michaud, J Turgeon Clinical Case Reports 8 (2), 305-312, 2020 | 13 | 2020 |
| Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease AL Elchynski, EJ Cicali, MC Ferrer del Busto, A Hamilton, KL Chang, ... The pharmacogenomics journal 21 (6), 657-663, 2021 | 10 | 2021 |
| Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators LH Cavallari, E Cicali, K Wiisanen, RB Fillingim, H Chakraborty, RA Myers, ... Clinical and Translational Science 15 (10), 2479-2492, 2022 | 8 | 2022 |
| The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice EJ Cicali, K Wiisanen Pharmacogenomics 23 (14), 749-752, 2022 | 8 | 2022 |
| Utilizing a Human–Computer interaction approach to evaluate the design of current pharmacogenomics clinical decision support AL Elchynski, N Desai, D D’Silva, B Hall, Y Marks, K Wiisanen, EJ Cicali, ... Journal of Personalized Medicine 11 (11), 1227, 2021 | 8 | 2021 |
| IGNITE network: Response of patients to genomic medicine interventions LA Orlando, C Voils, CR Horowitz, RA Myers, MJ Arwood, EJ Cicali, ... Molecular genetics & genomic medicine 7 (5), e636, 2019 | 8 | 2019 |
| Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved BE Gawronski, EJ Cicali, CW McDonough, LB Cottler, JD Duarte Frontiers in Genetics 13, 1085994, 2023 | 7 | 2023 |
| Reducing off-label antipsychotic use in older community-dwelling adults with dementia: A narrative review KT Bain, EJ Schwartz, R Chan-Ting Journal of Osteopathic Medicine 117 (7), 441-450, 2017 | 7 | 2017 |
| A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps E Eken, DS Estores, EJ Cicali, KK Wiisanen, JA Johnson Pharmacogenomics and Personalized Medicine, 645-664, 2023 | 6 | 2023 |
| Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States LK Lemke, B Alam, R Williams, P Starostik, LH Cavallari, EJ Cicali, ... Frontiers in Pharmacology 14, 1179364, 2023 | 5 | 2023 |
